Insmed, Inc. (INSM)
129.41
+2.13
(+1.67%)
USD |
NASDAQ |
Sep 11, 16:00
129.43
+0.02
(+0.02%)
After-Hours: 20:00
Insmed Price : 129.41 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 127.98 | 130.25 | 126.52 | 129.41 | 1.698M |
| Sep 10, 2026 | 127.22 | 128.85 | 124.29 | 127.28 | 2.595M |
| Sep 09, 2026 | 124.00 | 130.83 | 121.04 | 128.80 | 2.842M |
| Sep 08, 2026 | 124.78 | 127.42 | 121.38 | 124.89 | 1.605M |
| Sep 04, 2026 | 126.00 | 128.24 | 125.62 | 126.29 | 1.803M |
| Sep 03, 2026 | 126.70 | 127.09 | 124.05 | 126.68 | 1.886M |
| Sep 02, 2026 | 121.11 | 126.79 | 121.11 | 126.63 | 1.999M |
| Sep 01, 2026 | 121.95 | 122.19 | 119.52 | 121.51 | 1.419M |
| Aug 31, 2026 | 118.68 | 122.71 | 117.51 | 121.82 | 2.390M |
| Aug 28, 2026 | 120.11 | 120.66 | 117.15 | 118.54 | 1.978M |
| Aug 27, 2026 | 124.67 | 126.10 | 121.21 | 121.39 | 1.056M |
| Aug 26, 2026 | 122.89 | 125.59 | 121.64 | 124.39 | 1.980M |
| Aug 25, 2026 | 124.65 | 127.18 | 122.86 | 123.89 | 2.373M |
| Aug 24, 2026 | 125.03 | 126.11 | 122.83 | 123.98 | 1.341M |
| Aug 21, 2026 | 125.22 | 127.20 | 124.82 | 125.77 | 1.124M |
| Aug 20, 2026 | 128.36 | 130.27 | 124.60 | 125.08 | 1.762M |
| Aug 19, 2026 | 129.85 | 131.10 | 127.42 | 130.66 | 1.494M |
| Aug 18, 2026 | 128.07 | 128.93 | 126.39 | 128.46 | 1.274M |
| Aug 17, 2026 | 124.71 | 128.46 | 124.70 | 128.32 | 1.900M |
| Aug 14, 2026 | 125.67 | 126.84 | 122.21 | 123.74 | 1.957M |
| Aug 13, 2026 | 132.50 | 133.16 | 126.13 | 126.33 | 2.480M |
| Aug 12, 2026 | 132.31 | 135.26 | 130.80 | 132.28 | 1.563M |
| Aug 11, 2026 | 134.55 | 135.30 | 131.67 | 132.57 | 2.729M |
| Aug 10, 2026 | 129.98 | 135.50 | 129.50 | 134.75 | 3.630M |
| Aug 07, 2026 | 134.99 | 135.48 | 126.44 | 131.10 | 4.905M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Biogen, Inc. | 217.15 |
| Gilead Sciences, Inc. | 143.72 |
| Agios Pharmaceuticals, Inc. | 33.60 |
| Arcutis Biotherapeutics, Inc. | 23.88 |
Price Related Metrics
| PS Ratio | 24.41 |
| Price to Book Value | 37.29 |
| Earnings Yield | -3.17% |
| Market Cap | 28.25B |